Stock comparison
JOHNSON & JOHNSON is 116.1x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($622.64 B vs $5.36 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 116.1x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($622.64 B vs $5.36 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 116.1x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($622.64 B vs $5.36 B).
Revenue leader
JNJ
AMRX: $3.02B vs JNJ: $94.19B.
Profit leader
JNJ
AMRX: $72.06M vs JNJ: $26.80B.
Margin leader
JNJ
AMRX: 2.4% vs JNJ: 28.5% net margin.
| Metric | AMRX | JNJ |
|---|---|---|
| Market cap | $5.36 B | $622.64 B |
| US-listed rank | #1368 | #18 |
| Revenue (latest FY) | $3.02B | $94.19B |
| Net income (latest FY) | $72.06M | $26.80B |
| Net margin | 2.4% | 28.5% |
| P/E (trailing FY) | 74.4x | 23.2x |
| SEC filings | 664 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 116.1x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($622.64 B vs $5.36 B).
In their latest fiscal years, Amneal Pharmaceuticals, Inc. reported $3.02B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Amneal Pharmaceuticals, Inc. and JOHNSON & JOHNSON, or browse the full rankings.